Fennec Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Fennec Pharmaceuticals Inc (FENC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 56.6% of the shares are freely tradable; institutional investors hold 54.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.09 | 3,188,001 | +9.6 | 06/30/2026 |
| AIGH Capital Management, LLC | 7.09 | 2,486,038 | +25.5 | 06/30/2026 |
| Solas Capital Management LLC | 5.39 | 1,889,366 | -23.9 | 06/30/2026 |
| BlackRock Inc | 4.93 | 1,727,069 | +26.2 | 06/30/2026 |
| Awm Investment Company Inc | 3.31 | 1,160,296 | +61.1 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.39 | 839,306 | -6.4 | 06/30/2026 |
| Prospect Capital Advisors, LLC | 1.42 | 497,800 | +0.0 | 06/30/2026 |
| State Street Corp | 1.21 | 426,004 | +18.6 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.32 | 815,192 | +0.0 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.16 | 757,290 | -1.1 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Andrade Robert | CHIEF FINANCIAL OFFICER | 246,855 | 2,517,921 $ | Oct 12, 2026 | direct |
| Raykov Rosty | Former Director | 124,411 | 1,268,992 $ | Sep 1, 2026 | direct |
| Hackman Jeffrey S. | Chief Executive Officer | 69,685 | 710,787 $ | Oct 12, 2026 | direct |
| Cioffi Christiana Marie | Chief Strategy Officer | 28,746 | 293,209 $ | Oct 12, 2026 | direct |
| Evans Terry L | Chief Commercial Officer | 24,013 | 244,933 $ | Oct 12, 2026 | direct |
| Sayad Pierre Sargis | Chief Medical Officer | 13,533 | 138,037 $ | Oct 12, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Other | 3,946 | 5.53 | 21,821 |
| Oct 12, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Other | 3,846 | 5.53 | 21,268 |
| Oct 12, 2026 | Evans Terry L | Chief Commercial Officer | Other | 2,326 | 5.53 | 12,863 |
| Oct 12, 2026 | Hackman Jeffrey S. | Chief Executive Officer | Other | 2,224 | 5.53 | 12,299 |
| Oct 12, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Other | 3,846 | 5.53 | 21,268 |
| Sep 30, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Other | 156 | 0.00 | – |
| Sep 30, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Other | 168 | 0.00 | – |
| Sep 30, 2026 | Evans Terry L | Chief Commercial Officer | Other | 168 | 0.00 | – |
| Sep 30, 2026 | Hackman Jeffrey S. | Chief Executive Officer | Other | 1,159 | 0.00 | – |
| Sep 30, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Other | 1,703 | 0.00 | – |
| Sep 15, 2026 | Brughera Marco Maria | Director | Sell | 15,545 | 10.29 | 159,958 |
| Sep 15, 2026 | Brughera Marco Maria | Director | Other | 15,545 | 2.11 | 32,800 |
| Sep 1, 2026 | Raykov Rosty | Former Director | Sell | 10,000 | 12.11 | 121,100 |
| Aug 31, 2026 | Raykov Rosty | Former Director | Other | 2,778 | 0.00 | – |
| Aug 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Other | 156 | 0.00 | – |
| Aug 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Sell | 12,000 | 12.18 | 146,160 |
| Aug 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Other | 168 | 0.00 | – |
| Aug 31, 2026 | Evans Terry L | Chief Commercial Officer | Other | 168 | 0.00 | – |
| Aug 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer | Other | 1,159 | 0.00 | – |
| Aug 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Other | 1,703 | 0.00 | – |
| Aug 28, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Other | 21,928 | 5.10 | 111,833 |
| Aug 27, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Sell | 75,000 | 11.78 | 883,500 |
| Aug 3, 2026 | Raykov Rosty | Former Director | Sell | 10,000 | 9.58 | 95,800 |
| Jul 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Other | 156 | 0.00 | – |
| Jul 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Other | 168 | 0.00 | – |
| Jul 31, 2026 | Evans Terry L | Chief Commercial Officer | Other | 168 | 0.00 | – |
| Jul 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer | Other | 1,159 | 0.00 | – |
| Jul 31, 2026 | Raykov Rosty | Former Director | Other | 2,778 | 0.00 | – |
| Jul 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Other | 1,703 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.